03Jul
Committed to Clarity: FDA’s Dedication to Transparency with the End of ASR
On June 21, the Food and Drug Administration (FDA) released a report titled “Statement on agency’s efforts to increase transparency in medical device reporting.” This report describes updates to FDA’s Medical Device Reporting (MDR) Program, namely...
By:
Morrison & Foerster LLP
Related
Antitrust FAQs for Merging Parties - What modifications have the FTC and DOJ made for transactions ...
Read More >
The Ontario Superior Court of Justice recently found that a contractor infringed an architect’s des...
Read More >
Borrowers often envision future alterations to enhance the economic value of the commercial real est...
Read More >
Q: I heard New York prohibits employers from discriminating based on hairstyle. What does that mean...
Read More >
Non-compete clauses are commonly included in M&A agreements. Although generally recognized as lawful...
Read More >
The U.S. Department of Justice Antitrust Division ("DOJ") recently announced significant revisions t...
Read More >